Walleye Capital LLC Sangamo Therapeutics, Inc Transaction History

Walleye Capital LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.66 - $3.67 $9,782 - $21,627	5,893 Added 8.44%	75,699 $133,000
Q4 2022 Feb 14, 2023	SELL	$2.77 - $5.07 $72,044 - $131,865	-26,009 Reduced 27.15%	69,806 $219,000
Q3 2022 Nov 14, 2022	BUY	$4.27 - $6.39 $319,169 - $477,633	74,747 Added 354.79%	95,815 $469,000
Q2 2022 Aug 08, 2022	SELL	$3.28 - $6.21 $206,328 - $390,640	-62,905 Reduced 74.91%	21,068 $87,000
Q1 2022 May 16, 2022	BUY	$5.23 - $7.82 $439,178 - $656,668	83,973 New	83,973 $488,000

Q4 2021 Mar 03, 2022	SELL	$7.29 - $10.97 $83,579 - $125,771	-11,465 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.01 - $12.01 $103,299 - $137,694	11,465 New	11,465 $103,000
Q1 2021 May 17, 2021	SELL	$10.88 - $17.05 $290,496 - $455,235	-26,700 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$9.23 - $18.18 $246,441 - $485,406	26,700 New	26,700 $417,000
Q3 2019 Nov 14, 2019	SELL	$9.05 - $12.22 $205,425 - $277,381	-22,699 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$8.75 - $13.03 $188,991 - $281,434	21,599 Added 1963.55%	22,699 $244,000
Q1 2019 May 15, 2019	BUY	$7.72 - $12.81 $8,492 - $14,091	1,100 New	1,100 $10,000

138

100M

35.5K

65.8K

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $50.1M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.